This is from Mr Allan Q & A
"Andrew Froude (General Manager - Preclinical Research Products): Andrew Froude is
responsible for ViewnVivo. Whilst sales in this area have been well below expectations, we
believe there is a strong market for this product so we have commenced discussions with
replacements."
Ann: Successful European conference participation, page-4
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 47030 | 2 |
View Market Depth
| Last trade - 07.02am 02/12/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
Day chart unavailable
